Interview: Vatché Bartekian – President, Vantage BioTrials, Canada

Introducing Vantage BioTrials, a CRO focused on operational excellence with a lean and holistic approach to each project, Vatché Bartekian, president and co-founder, also advocates for greater visibility for Canada on the international stage and an increase in collaboration within the pharmaceutical industry and regulatory bodies. Vantage BioTrials celebrated its tenth anniversary last year. What gap did you identify in 2007 for Vantage BioTrials to fill?
"What we can observe in Canada is a very diverse CRO landscape, in which each player has found its own specialty."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report